What is the appropriate emergency management for an adult with diabetic ketoacidosis and altered mental status (Glasgow Coma Scale ≤ 8)?

Emergency Management of DKA with Altered Mental Status

An adult with diabetic ketoacidosis and altered mental status (GCS ≤8) requires immediate ICU admission with continuous intravenous insulin infusion, aggressive fluid resuscitation, and careful electrolyte monitoring—this is a life-threatening emergency demanding intensive care-level management.

Immediate Assessment and Monitoring

Upon presentation, obtain the following STAT 1, 2:

• Arterial or venous blood gases (venous pH typically 0.03 lower than arterial)
• Complete metabolic panel including electrolytes, BUN, creatinine, calcium, phosphorus
• Blood glucose and serum osmolality
• Complete blood count with differential
• Urinalysis for ketones
• ECG
• Chest X-ray and cultures as clinically indicated

Monitor blood glucose and electrolytes every 2-4 hours during active treatment 1, 2. Venous pH and anion gap are sufficient for monitoring acidosis resolution—repeat arterial blood gases are generally unnecessary 1, 2.

Fluid Resuscitation

Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L in the first hour for most adults) 2. This initial aggressive fluid replacement is critical for restoring intravascular volume and tissue perfusion 1.

After the initial hour 2:

• If corrected serum sodium is normal or elevated: switch to 0.45% NaCl at 250-500 mL/hour
• If corrected serum sodium is low: continue 0.9% NaCl at 250-500 mL/hour
• Correct serum sodium by adding 1.6 mEq/L for every 100 mg/dL glucose above 100 mg/dL 2

The rate of osmolality correction should not exceed 3 mOsm/kg/hour to minimize cerebral edema risk 2. In patients with altered mental status, this is particularly critical 3.

Insulin Therapy

Do NOT start insulin until potassium is ≥3.3 mEq/L 2. If potassium is below this threshold, aggressive potassium replacement must precede insulin therapy.

Once hypokalemia is excluded 2:

• Give 0.15 units/kg IV bolus of regular insulin (approximately 10 units for a 70 kg adult)
• Follow immediately with continuous IV infusion at 0.1 units/kg/hour (approximately 7 units/hour for a 70 kg adult)

Target glucose reduction of 50-75 mg/dL per hour 2. If glucose does not fall by at least 50 mg/dL in the first hour, verify adequate hydration status and double the insulin infusion rate hourly until achieving steady glucose decline 2.

When plasma glucose reaches 250 mg/dL 2:

• Decrease insulin infusion to 0.05-0.1 units/kg/hour (3-6 units/hour)
• Add dextrose 5-10% to IV fluids
• Continue insulin infusion until DKA resolves (pH >7.3, bicarbonate ≥18 mEq/L, anion gap closure)

Potassium Management

Potassium replacement is mandatory once urine output is established 2. Insulin therapy drives potassium intracellularly, and hypokalemia during DKA treatment is common (approximately 50% of cases) and associated with increased mortality 4.

Potassium replacement protocol 2:

• If K+ <3.3 mEq/L: hold insulin, give potassium 20-30 mEq/hour until K+ ≥3.3 mEq/L
• If K+ 3.3-5.2 mEq/L: add 20-40 mEq potassium to each liter of IV fluid (use 2/3 KCl and 1/3 KPO₄)
• If K+ >5.2 mEq/L: do not give potassium but check levels every 2 hours

Bicarbonate Therapy

Bicarbonate therapy is NOT routinely recommended 1. Studies show no benefit in resolution of acidosis or time to discharge 5.

Consider bicarbonate only if pH <6.9 1:

• Give 100 mmol sodium bicarbonate in 400 mL sterile water with 20 mEq KCl over 2 hours
• Repeat every 2 hours until pH >7.0

Phosphate Replacement

Routine phosphate replacement does not improve clinical outcomes 1. However, careful phosphate replacement may be indicated in patients with 1:

• Cardiac dysfunction
• Anemia
• Respiratory depression
• Serum phosphate <1.0 mg/dL

When indicated, add 20-30 mEq/L potassium phosphate to IV fluids 2.

Cerebral Edema Risk

Altered mental status in DKA raises significant concern for cerebral edema, particularly if mental status worsens during treatment 2. This complication, while more common in pediatric patients, can occur in adults.

To minimize cerebral edema risk 2:

• Avoid excessive fluid administration rates
• Ensure gradual correction of glucose and osmolality (not exceeding 3 mOsm/kg/hour)
• Use isotonic or hypotonic saline based on corrected sodium and hemodynamic status
• Monitor neurological status closely throughout treatment

Resolution Criteria and Transition

DKA is resolved when ALL of the following are met 1, 5:

• Glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH >7.3
• Anion gap closure

Critical transition step: Give subcutaneous basal insulin 2-4 hours BEFORE stopping IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis 5, 6. This is a common pitfall—premature termination of IV insulin without adequate subcutaneous insulin overlap leads to DKA recurrence 6.

Special Considerations

SGLT2 inhibitors: If the patient was taking SGLT2 inhibitors, be aware these medications increase risk of euglycemic DKA (normal or near-normal glucose with ketoacidosis) 7, 8, 9, 10. These agents should have been discontinued 3-4 days before any elective procedure 5, 8.

Precipitating factors: Aggressively identify and treat the underlying cause 1, 11:

• Infection (most common)
• Myocardial infarction or stroke
• Medication non-adherence
• New diagnosis of diabetes

Common Pitfalls to Avoid

1. Starting insulin before correcting hypokalemia (K+ must be ≥3.3 mEq/L) 2
2. Stopping IV insulin too early before all resolution criteria are met 6
3. Inadequate overlap between IV and subcutaneous insulin (must give basal insulin 2-4 hours before stopping IV) 5, 6
4. Overly rapid correction of osmolality (>3 mOsm/kg/hour increases cerebral edema risk) 2, 3
5. Using sliding-scale insulin alone without basal insulin coverage 12, 5
6. Relying on urine ketones to monitor treatment response (β-hydroxybutyrate is preferred but acetoacetate measured by nitroprusside method can falsely suggest worsening ketosis during treatment) 1, 2